Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 19.8% in December

Sharps Technology, Inc. (NASDAQ:STSS) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 110,000 shares, a decline of 19.8% from the December 15th total of 137,200 shares. Based on an average daily volume of 178,600 shares, the short-interest ratio is presently 0.6 days. Approximately 6.4% of the company’s shares are sold short.

Sharps Technology Stock Down 1.6 %

STSS traded down $0.03 during midday trading on Thursday, reaching $1.88. 26,632 shares of the company’s stock traded hands, compared to its average volume of 39,063. Sharps Technology has a 52 week low of $1.70 and a 52 week high of $18.15. The firm has a fifty day moving average price of $2.45. The company has a market cap of $3.85 million, a PE ratio of -0.23 and a beta of 1.56.

Institutional Trading of Sharps Technology

A hedge fund recently bought a new stake in Sharps Technology stock. Garden State Investment Advisory Services LLC acquired a new position in Sharps Technology, Inc. (NASDAQ:STSS) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned approximately 8.45% of Sharps Technology at the end of the most recent quarter. 17.17% of the stock is owned by institutional investors.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.